Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992
See this aricle in Pubmed

Article Abstract
Four randomized trial reported major clinical end points.In these, ticlopidine was more effective than placebo for preventing recurrences after completed stroke;was more effective than aspirin for patients with transient ischemic attacks and partial strokes;and reduced vascular death and nonfatal myocardial infarction in an open trail among patients with unstable angina.For patients with intermittent claudication ticlopidine, was not significantly better than placebo for preventing myocardial infarction or stroke.Side effects were more common with ticlopidine than with aspirin or placebo.Conclusions.-Ticlopidine should be prescribed in place of aspirin for stroke prophylaxis or unstable angina if the patient is unable to tolerate aspirin.Ticlopidine may also benefit patients who experience new ischemic events while taking aspirin or,probably,patients with peripheral vascular disease.A complete blood cell count should be performed every 2 weeks during the first 3 months of therapy to check for leukopenia.
 
Related Tags
(click to filter results - removes previous filter)

adverse drug reaction
aspirin
cerebrovascular accident,prevention of
cerebrovascular accident,women
leukopenia
platelet inhibiting drugs
review article
ticlopidine

Click Here to return To Results